Enhanced specificity of the p53 family proteins-based adenoviral gene therapy in uterine cervical cancer cells with E2F1-responsive promoters.

Source:http://linkedlifedata.com/resource/pubmed/id/17012841

Download in:

View as

General Info

PMID
17012841